India Roundup: PharmEasy to file for $934m IPO, and more 

PharmEasy’s parent firm to file for US$934 million IPO

• API Holdings, the parent firm of PharmEasy, is reportedly set to file its draft papers for its initial public offering by the next week.
• The healthtech firm’s listing is likely to only include the sale of primary shares. The offer size could potentially be expanded by about 20%.
• The Temasek-backed firm recently shelled out about US$613 million to buy a 66.1% stake in Thyrocare Technologies, one of the country’s largest diagnostics laboratory chains. (Read: A landmark deal: The $600m buyout by a Temasek-backed Indian e-pharmacy unicorn)

Policybazaar raises US$343 million in IPO anchor round

• The SoftBank-backed firm’s anchor slot has been oversubscribed by 40x. So far, Fidelity, Baillie Gifford, Dragoneer Group, BlackRock, Steadview Capital, Tiger Global, and Falcon Edge have all invested in Policybazaar.
• Anchor investors, including insurance firms such as  HDFC Life, ICICI Prudential, Bajaj Allianz Life, SBI General Insurance, and Max Life Insurance, joined Policybazaar’s IPO.
• The policy marketplace’s founders, Yashish Dahiya and Alok Bansal, have reportedly decided not to sell about 85% to 90% of the shares they had initially planned to.